학술논문
TCT-642 The Comparative Effectiveness and Safety of Cangrelor vs. In- lab Glycoprotein IIb/IIIa Inhibitor (GPI) in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
Document Type
Abstract
Author
Source
In Journal of the American College of Cardiology 25 September 2018 72(13) Supplement:B256-B257
Subject
Language
ISSN
0735-1097